Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev Neurol ; 45(10): 607-14, 2007.
Artigo em Espanhol | MEDLINE | ID: mdl-18008267

RESUMO

AIM: To present a panorama of the main features and possible identity of the synaptic tag, such as to discuss some of its functional implications. DEVELOPMENT: Long-term potentiation (LTP) constitutes a very attractive synaptic/cellular memory model. LTP, like memory, can manifest itself early (essentially depending on the modification of pre-existing proteins at synapse) and late (depending on new protein synthesis). As LTP is a highly specific phenomenon, a dilemma arises: how can the proteins, required to plastic change stabilization, that are synthesized at the soma of a neuron containing thousands of synaptic contacts--all depending of the same nucleus--go to the appropriate synapses? In this review, we present some of the models that intend to explain this question, making emphasis on synaptic tagging hypothesis. Some of the main findings that have contributed to tagging hypothesis are exposed. The local protein synthesis and the activation of protein kinases are analyzed as candidates to be the synaptic tag. Additionally, some of the functional implications of synaptic tagging are discussed. CONCLUSIONS: The synaptic tagging hypothesis offers a very flexible and reasonable solution to the specificity of long-lasting synaptic changes. Although some of the tagging features are known, the synaptic tag identity has not yet been elucidated. It seems that there is not a unique synaptic tag, but there are rather multiple molecular synaptic tags involved. Each of them might function as a synaptic tag under particular circumstances. Each might be differentially recruited by specific stimuli and mediate plasticity over different time domains.


Assuntos
Potenciação de Longa Duração/fisiologia , Memória/fisiologia , Sinapses/fisiologia , Proteínas Quinases Dependentes de Cálcio-Calmodulina/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Modelos Neurológicos , Plasticidade Neuronal/fisiologia , Sinapses/ultraestrutura
2.
Rev. neurol. (Ed. impr.) ; 45(10): 607-614, 16 nov., 2007. ilus
Artigo em Es | IBECS | ID: ibc-65814

RESUMO

Presentar una visión de las principales características y posible identidad de la marca sináptica, así comodiscutir algunas de sus implicaciones funcionales. Desarrollo. La potenciación sináptica a largo plazo, dadas sus características, se ha impuesto como un modelo sinapticocelular de memoria muy atractivo. De modo similar a la memoria, puede manifestarse como temprana (dependiente fundamentalmente de la modificación de proteínas preexistentes en la sinapsis) otardía (dependiente de la síntesis de nuevas proteínas). Debido a que la potenciación sináptica a largo plazo es un fenómeno altamente específico, surge un dilema: ¿cómo llegan a las sinapsis apropiadas las proteínas requeridas para la estabilizacióndel cambio plástico en una neurona que normalmente posee miles de contactos sinápticos, todos dependientes del mismo núcleo? En este trabajo se presentan algunos de los modelos que aportan posibles soluciones a este interrogante, haciendo énfasisen la hipótesis del marcaje sináptico. Se exponen los principales hallazgos que han ido conformando esta hipótesis y se analiza la síntesis local y la activación de proteincinasas como posibles candidatos de ser la marca sináptica. Adicionalmente, sediscuten algunas implicaciones funcionales del marcaje sináptico. Conclusiones. La hipótesis de la marca sináptica ofrece una explicación muy flexible y razonable acerca de la especificidad del cambio sináptico duradero. Aunque se conocen algunas desus características, la identidad de la marca no se ha dilucidado aún. Al parecer, existen múltiples marcas que, al ser reclutadas por estímulos específicos, median los efectos plásticos en diferentes dominios temporales


To present a panorama of the main features and possible identity of the synaptic tag, such as to discuss someof its functional implications. Development. Long-term potentiation (LTP) constitutes a very attractive synaptic/cellular memory model. LTP, like memory, can manifest itself early (essentially depending on the modification of pre-existing proteins atsynapse) and late (depending on new protein synthesis). As LTP is a highly specific phenomenon, a dilemma arises: how can the proteins, required to plastic change stabilization, that are synthesized at the soma of a neuron containing thousands ofsynaptic contacts –all depending of the same nucleus– go to the appropriate synapses? In this review, we present some of the models that intend to explain this question, making emphasis on synaptic tagging hypothesis. Some of the main findings that have contributed to tagging hypothesis are exposed. The local protein synthesis and the activation of protein kinases areanalyzed as candidates to be the synaptic tag. Additionally, some of the functional implications of synaptic tagging are discussed. Conclusions. The synaptic tagging hypothesis offers a very flexible and reasonable solution to the specificity oflong-lasting synaptic changes. Although some of the tagging features are known, the synaptic tag identity has not yet been elucidated. It seems that there is not a unique synaptic tag, but there are rather multiple molecular synaptic tags involved.Each of them might function as a synaptic tag under particular circumstances. Each might be differentially recruited by specific stimuli and mediate plasticity over different time domains


Assuntos
Humanos , Sinapses/fisiologia , Memória/fisiologia , Proteínas Quinases/fisiologia , Transmissão Sináptica/fisiologia
3.
Rev Neurol ; 38(10): 957-71, 2004.
Artigo em Espanhol | MEDLINE | ID: mdl-15175980

RESUMO

AIMS: The purpose of this work was to gather the information currently available about the content of nerve growth factor (NGF) in experimental models of neurodegeneration and in neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases, as well as to analyse how NGF content is affected by the application of different neurorestorative therapies (transplant and trophic therapy) in these neurological entities. DEVELOPMENT: Neurotrophins are proteins that promote the differentiation, growth and survival of many populations of peripheral neurons and the central nervous system during development and adulthood. NGF is the best known and most widely researched member of this family, which is also made up of the growth factor derived from the brain and neurotrophins 3, 4/5, 6 and 7. In the last few decades, significant progress has been made in the knowledge available about the biological role played by these factors, their molecular characterisation and regulation, as well as their signalling mechanisms. Yet, little is known about the role played by the neurotrophic factors in neurodegenerative diseases or whether the levels of these factors are modified following the use of neurorestorative treatment. CONCLUSIONS: Neurodegenerative disorders, especially Parkinson and Alzheimer, are accompanied by modifications in the levels of NGF that depend on the extent to which the disease has progressed. A model of the changes in NGF content during neurodegenerative processes is also proposed.


Assuntos
Fator de Crescimento Neural/metabolismo , Fator de Crescimento Neural/uso terapêutico , Doenças Neurodegenerativas/tratamento farmacológico , Doenças Neurodegenerativas/metabolismo , Animais , Transplante de Células , Modelos Animais de Doenças , Progressão da Doença , Humanos , Fator de Crescimento Neural/genética , Regeneração Nervosa/fisiologia , Receptores de Fator de Crescimento Neural/metabolismo
4.
Rev Neurol ; 38(10)May 2004. graf
Artigo em Inglês | CUMED | ID: cum-40113

RESUMO

AIMS: The purpose of this work was to gather the information currently available about the content of nerve growth factor (NGF) in experimental models of neurodegeneration and in neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases, as well as to analyse how NGF content is affected by the application of different neurorestorative therapies (transplant and trophic therapy) in these neurological entities. DEVELOPMENT: Neurotrophins are proteins that promote the differentiation, growth and survival of many populations of peripheral neurons and the central nervous system during development and adulthood. NGF is the best known and most widely researched member of this family, which is also made up of the growth factor derived from the brain and neurotrophins 3, 4/5, 6 and 7. In the last few decades, significant progress has been made in the knowledge available about the biological role played by these factors, their molecular characterisation and regulation, as well as their signalling mechanisms. Yet, little is known about the role played by the neurotrophic factors in neurodegenerative diseases or whether the levels of these factors are modified following the use of neurorestorative treatment. Neurodegenerative disorders, especially Parkinson and Alzheimer, are accompanied by modifications in the levels of NGF that depend on the extent to which the disease has progressed. A model of the changes in NGF content during neurodegenerative processes is also proposed(AU)


Assuntos
Humanos , Doenças Neurodegenerativas/tratamento farmacológico , Doenças Neurodegenerativas/metabolismo , Fator de Crescimento Neural/genética , Fator de Crescimento Neural/metabolismo
5.
Rev. neurol. (Ed. impr.) ; 38(10): 957-971, 16 mayo, 2004.
Artigo em Es | IBECS | ID: ibc-32606

RESUMO

Objetivos. El propósito del presente trabajo es recopilar la información disponible sobre el contenido del factor de crecimiento nervioso (NGF, del inglés nerve growth factor) en modelos experimentales de neurodegeneración y en enfermedades neurodegenerativas, entre ellas las enfermedades de Alzheimer, Parkinson y Huntington, así como analizar el efecto que causa en la concentración de NGF la aplicación de diversos tratamientos nerorrestauradores (trasplante y terapia trófica) en estas entidades neurológicas. Desarrollo. Las neurotrofinas son proteínas que promueven la diferenciación, crecimiento y supervivencia de muchas poblaciones de neuronas periféricas y del sistema nervioso central durante el desarrollo y la vida adulta. El NGF es el miembro más conocido y estudiado de dicha familia, compuesta, además, por el factor de crecimiento derivado del cerebro y las neurotrofinas 3, 4/5, 6 y 7. En las últimas décadas se han realizado avances significativos en el conocimiento de la función biológica de estos factores, su caracterización molecular y regulación, así como sus mecanismos de señalización; sin embargo, poco se sabe sobre el papel que desempeñan los factores neurotróficos en las enfermedades neurodegenerativas, ni si se modifica la concentración de estos factores después de la utilización de tratamientos neurorrestauradores. Conclusiones. Los trastornos neurodegenerativos, en especial el Parkinson y el Alzheimer, se acompañan de modificaciones en la concentración de NGF que dependen del progreso de la enfermedad. Se propone un modelo de los cambios en el contenido del NGF durante los procesos neurodegenerativos (AU)


Aims. The purpose of this work was to gather the information currently available about the content of nerve growth factor (NGF) in experimental models of neurodegeneration and in neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s diseases, as well as to analyse how NGF content is affected by the application of different neurorestorative therapies (transplant and trophic therapy) in these neurological entities. Development. Neurotrophins are proteins that promote the differentiation, growth and survival of many populations of peripheral neurons and the central nervous system during development and adulthood. NGF is the best known and most widely researched member of this family, which is also made up of the growth factor derived from the brain and neurotrophins 3, 4/5, 6 and 7. In the last few decades, significant progress has been made in the knowledge available about the biological role played by these factors, their molecular characterisation and regulation, as well as their signalling mechanisms. Yet, little is known about the role played by the neurotrophic factors in neurodegenerative diseases or whether the levels of these factors are modified following the use of neurorestorative treatment. Conclusions. Neurodegenerative disorders, especially Parkinson and Alzheimer, are accompanied by modifications in the levels of NGF that depend on the extent to which the disease has progressed. A model of the changes in NGF content during neurodegenerative processes is also proposed (AU)


Assuntos
Humanos , Animais , Fator de Crescimento Neural , Regeneração Nervosa , Doenças Neurodegenerativas , Receptores de Fator de Crescimento Neural , Transplante de Células , Modelos Animais de Doenças , Progressão da Doença
6.
Rev Neurol ; 37(7): 619-22, 2003.
Artigo em Espanhol | MEDLINE | ID: mdl-14582016

RESUMO

INTRODUCTION: Numerous reports show that lesions to hippocampus afferents, such as the entorhinal cortex (EC) and the fimbria fornix (FF), exert an effect on memory in rodents. There are, however, no long term comparative studies that show which of these lesions could be most useful as a model for studies into neuroplasticity. MATERIAL AND METHODS: Young male Sprague Dawley rats were used. Bilateral electrolytic lesion was caused to the EC or the FF was damaged by transection. One, four or 12 weeks later the animals were evaluated in a Morris water maze, first with an invisible platform and then with the platform within view. The results from the two groups were compared to each other and to those obtained from healthy controls and subjects with false lesions by means of a variance analysis. RESULTS: In the test with an invisible platform, both types of lesion gave rise to serious, irreparable involvement of the spatial memory of the animals, at least up to 12 weeks after the lesion. The test with the visible platform revealed significant differences between animals with lesion to the EC evaluated at 12 weeks, which suggests the development of some visual or motor deterioration in these animals. CONCLUSIONS: Although both lesions gave rise to behavioural deterioration that was irreversible in the long term in rodents, the lesion to the FF seems to be a better model for evaluating specific effects on learning and memory, since the lesion to the EC apparently triggers additional sensory and motor involvement.


Assuntos
Encefalopatias/patologia , Córtex Entorrinal/patologia , Fórnice/patologia , Memória/fisiologia , Animais , Encefalopatias/fisiopatologia , Humanos , Masculino , Aprendizagem em Labirinto , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
7.
Rev Neurol ; 36(9): 877-86, 2003.
Artigo em Espanhol | MEDLINE | ID: mdl-12717677

RESUMO

OBJECTIVE: To review the main findings on the glutathione role in cognitive function and synaptic plasticity processes, as well as, its involvement in neurotrophic and neurodegenerative events in rodents. DEVELOPMENT: The tripeptide glutathione and its related enzymes participate in the maintenance of oxidant homeostasis in aerobic cells. Oxidative damage to neuronal components underlies the molecular basis of neurodegeneration and brain aging. Several biomolecules with redox dependent activity are involved in the neuronal plasticity events that have a role in learning and memory functions. The maintenance of normal glutathione level is important for acquisition, but not consolidation, of spatial memory. Glutathione unavailability induces failures in hippocampal synaptic plasticity mechanisms, which are possibly related to a spatial memory deficit. On the other hand, several studies have suggested that the beneficial effects of neurotrophic treatments are mediated by the modulation of antioxidant defense mechanisms. In fact, nerve growth factor treatment to cognitively impaired rats stimulates glutathione reductase and can prevent the increases in glutathione peroxidase activity, pointing these enzymes as possible intracellular targets of neurotrophin actions on oxidant homeostasis. CONCLUSION: There is a closed link between glutathione metabolism and oxidant homeostasis, which is expressed in learning and synaptic plasticity deficits in conditions of low glutathione content, as well as, in neurodegeneration induced glutathione metabolism changes that can be prevented by neurotrophic treatment


Assuntos
Transtornos Cognitivos/etiologia , Glutationa/metabolismo , Doenças Neurodegenerativas/complicações , Doenças Neurodegenerativas/metabolismo , Envelhecimento/fisiologia , Hipocampo/metabolismo , Hipocampo/patologia , Hipocampo/fisiopatologia , Humanos , Deficiências da Aprendizagem/etiologia , Transtornos da Memória/etiologia , Fatores de Crescimento Neural/uso terapêutico , Doenças Neurodegenerativas/tratamento farmacológico , Oxirredução , Estresse Oxidativo/fisiologia , Receptores de N-Metil-D-Aspartato/metabolismo , Transmissão Sináptica/fisiologia
8.
Rev Neurol ; 35(6): 586-93, 2002.
Artigo em Espanhol | MEDLINE | ID: mdl-12389177

RESUMO

INTRODUCTION: Memory is initially stored as a transitory change that can become consolidated and converted into a long term memory trace. Consolidation largely depends on the emotional state. It is known that the hippocampus plays a role in the consolidation process of certain types of memory and that the amygdala might modulate the consolidation of the memory traces in other parts of the brain. The interaction between these two structures is crucial in many forms of learning and memory. METHOD: The hippocampus, as well as the amygdala, display a type of synaptic plasticity known as long term potentiation (LTP), which is considered to be a cellular memory mechanism. Recently, it has been reported that the consolidation of the hippocampal LTP may be modulated, like memory, by the emotional state and by the activation of the basolateral amygdala. These findings, taken as a whole, can help to explain how the processes of consolidation of memory take place. At the same time they also constitute a more physiological model of the learning and memory processes, which will provide us with a more accurate understanding of the mechanisms behind the consolidation of the memory.


Assuntos
Tonsila do Cerebelo/fisiologia , Hipocampo/fisiologia , Memória/fisiologia , Motivação , Transmissão Sináptica/fisiologia , Animais , Humanos , Reforço Psicológico
9.
J Neurosci ; 21(10): 3697-703, 2001 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-11331399

RESUMO

The basolateral amygdala (BLA) can influence distinct learning and memory formation. Hippocampal long-term potentiation (LTP), the most prominent cellular model of memory formation, can be modulated by stimulation of the BLA in its induction and early maintenance. However, it is not known how the late maintenance of LTP beyond its initial phases might be affected. Behavioral stimuli have been shown to result in a reinforcement of a transient early-LTP into a lasting potentiation. Here we show that BLA stimulation mimics the behavioral effects on early-LTP in freely moving rats when the BLA is activated within a time window of 30 min before or after tetanization of the perforant path. The reinforcement of LTP was blocked by inhibitors of muscarinergic and beta-adrenergic but not dopaminergic receptors and was dependent on translation. Through these heterosynaptic associative interactions, hippocampal sensory information can be stabilized by amygdaloidal influences.


Assuntos
Tonsila do Cerebelo/fisiologia , Giro Denteado/fisiologia , Potenciação de Longa Duração/fisiologia , Transmissão Sináptica/fisiologia , Antagonistas Adrenérgicos beta/farmacologia , Animais , Antagonistas de Dopamina/farmacologia , Estimulação Elétrica , Eletrodos Implantados , Antagonistas de Aminoácidos Excitatórios/farmacologia , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Potenciais Pós-Sinápticos Excitadores/fisiologia , Potenciação de Longa Duração/efeitos dos fármacos , Antagonistas Muscarínicos/farmacologia , Via Perfurante/fisiologia , Inibidores da Síntese de Proteínas/farmacologia , Ratos , Ratos Wistar , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Vigília
10.
Rev Neurol ; 31(11): 1074-95, 2000.
Artigo em Espanhol | MEDLINE | ID: mdl-11190877

RESUMO

OBJECTIVE: To present a unified vision of the principal known mechanisms of neuroplasticity, emphasizing their universality. DEVELOPMENT: The concept of the central nervous system as an immutable entity has been considerably modified during the second half of the 20th century. Neuroplasticity, that is the ability of the brain regarding change and repair is expressed in different ways, from functional modifications of existing structures to the formation, by growth and proliferation, of new structures and neurons. This study considers the molecular and cellular mechanisms of neuroplastic phenomena and classifies them into two main groups: plasticity due to growth, including the mechanisms of axonal regeneration, collateralization and reactive synaptogenesis; and functional plasticity, which includes changes in the efficacy of synaptic transmission such as long-term potentiation and the activation of silent synapses. We also describe some of the relations of neuroplastic phenomena with disease of the central nervous system, together with examples of physiological, physical and pharmacological factors which may be used in future as therapeutic tools to stimulate and modulate neuroplasticity. CONCLUSION: Neuroplastic mechanisms show a high degree of phylogenetic and ontogenetic conservation. They are important both in the genesis of disorders and disease of the nervous system and for its repair after different types of damage and trauma. Modulation of neuroplastic mechanisms by physical and chemical agents would appear to be one of the most powerful therapeutic tools of restorative neurology.


Assuntos
Plasticidade Neuronal/fisiologia , Neurônios/citologia , Animais , Humanos , Neurônios/fisiologia
11.
Rev Neurol ; 29(8): 704-8, 1999.
Artigo em Espanhol | MEDLINE | ID: mdl-10560104

RESUMO

INTRODUCTION: Lesion of the fimbria-fornix causes dysfunction of learning processes and has been used in animal models for the study of Alzheimer's disease. MATERIAL AND METHODS: With the objective of comparing the efficacy of two methods of producing a lesion of the fimbria-fornix, 40 young male Sprague-Dawley rats were distributed in four experimental groups: control (6), falsely lesioned (8), lesion due to aspiration (12) and lesion due to transection (14). RESULTS: The results showed that whilst with both techniques, in rats, serious cognitive defects were produced, as expressed by the high latencies of escape and small number of crossings of Morris's aquatic labyrinth, the aspiration lesion led to greater mortality than the transection lesion did. Similarly, the aspiration technique in rats induced hyperactivity, aggressiveness and tigmotaxia, while in the rats with lesions due to transection tigmotaxia ceased after their first attempts and hyperactivity on the second day of training. CONCLUSION: These results would suggest that a bilateral lesion due to transection of the fimbria-fornix is an effective alternative to an aspiration lesion to interrupt this pathway.


Assuntos
Fórnice/patologia , Fórnice/cirurgia , Doença de Alzheimer , Animais , Biópsia por Agulha/métodos , Transtornos Cognitivos/diagnóstico , Modelos Animais de Doenças , Aprendizagem/fisiologia , Masculino , Ratos , Ratos Sprague-Dawley
12.
La Habana; s.n; 1999. 12 p. graf.
Não convencional em Espanhol | CUMED | ID: cum-16411

RESUMO

Se utilizaron 21 ratas Sprague Dawley machos de 8 semanas fueron empleadas para estudiar la influencia de la frecuencia de estimulación sobre la plasticidad sináptica en el giro dentado. Bajo anestesia (hidrato de cloral, 420 mg/kg) se implantaron electrodos de registro en el giro dentado y de estimulación en la vía perforante. Antes de la estimulación tetánica se construyó una curva estímulo-respuesta, las interacciones sinápticas a corto plazo (pulsos pareados con 30, 50, 70 y 90 mseg de intervalo entre estímulos). La estimulación tetánica se hizo utilizando trenes de 10 impulsos cada 10 minutos a frecuencias de 10, 50, 100, 200 y 400 Hz respectivamente durante dos horas consecutivas. Entre cada tren se tomaron registros de prueba. Al finalizar la serie se hizo una nueva curva estímulo-respuesta y se estudiaron nuevamente los impulsos pareados. La estimulación a 200 Hz produjo una potenciación de ambas variables estudiadas (pendiente de PPSE y amplitud de la espiga poblacional). Frecuencias interiores tuvieron efectos menos claros mientras que la estimulación a 400 Hz produjo un aumento de la espiga poblacional, pero una disminución de la pendiente del PPSE. Esto se manifestó también en cambios similares en las curvas estímulo-respuesta. La estimulación tetánica también modificó las relaciones a corto plazo provocando todas las frecuencias superiores a 10 Hz un predominio de los procesos de inhibición recíproca(AU)


Assuntos
Potenciação de Longa Duração , Hipocampo , Ratos , Modelos Animais de Doenças
13.
Fundam Clin Pharmacol ; 12(5): 538-45, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9794152

RESUMO

Neurotrophins, like the nerve growth factor (NGF), trigger a variety of biological effects in their targets. Stimulating effects on antioxidant defenses have been postulated to underlie neurotrophic influence on neuron survival and maintenance. To test whether NGF is capable of inducing changes in glutathione-related enzymes in the aged cognitively impaired brain, glutathione reductase (GRD), glutathione S-transferase (GST) and total glutathione peroxidase (GPX) activities were measured in the striatum, septum, hippocampus and frontal cortex of four Sprague-Dawley rat groups: young (2 months old), aged (20 months old) untreated, aged cytochrome c-treated, and aged NGF-treated (icv delivery, 34 micrograms during 28 days). All the aged rats utilized in the study were memory impaired according to their performance in the Morris water maze test. These aged rats showed increases in the activities of septal and hippocampal GST, as well as, in the hippocampal, striatal and cortical GPX. These increases could be interpreted as compensatory responses to cope with the oxidative damage that has been accumulated by the aged brain. The increases in hippocampal and cortical GPX activity were attenuated by NGF treatment, whereas the neurotrophin induced an increase in GRD activity in the striatum of aged rats. These results point out GRD and GPX as possible targets of the neurotrophic effects.


Assuntos
Córtex Cerebral/efeitos dos fármacos , Glutationa Peroxidase/metabolismo , Glutationa Redutase/metabolismo , Glutationa Transferase/metabolismo , Hipocampo/efeitos dos fármacos , Fatores de Crescimento Neural/farmacologia , Análise de Variância , Animais , Córtex Cerebral/enzimologia , Transtornos Cognitivos/enzimologia , Transtornos Cognitivos/metabolismo , Ativação Enzimática , Hipocampo/enzimologia , Masculino , Ratos , Ratos Sprague-Dawley
14.
La Habana; s.n; 1998. 7 p. graf.
Não convencional em Inglês | CUMED | ID: cum-13257

RESUMO

Neurotrophins, like the nerve growth factor (NGF), trigger a variety of biological effects in their targets. Stimulating effects on antioxidant defenses have been postulated to underlie neurotrophic influence on neuron survival and maintenance. To test whether NGF is capable of inducing changes in glutathione-related enzymes in the aged cognitively impaired brain, glutathione reductase (GRD), glutathione S-transferase (GST) and total glutathione peroxidase (GPX) activities were measured in the striatum, septum, hippocampus and fraontal cortex of four Sprague-Dawley rat groups: young (2 months old), aged (20 months old) untreated, aged cytochrome c-treated, and aged NGF-treated (icv delivery, 34 æg during 28 days). All the aged rats utilized in the study were memory impaired according to their performance in the Morris water maze test. These aged rats showed increases in the activities of septal and hippocampal GST, as well as, in the hippocampal, striatal and cortical GPX. These increases could be interpreted as compensatory responses to cope with the oxidative damage that has been accumulated by the aged brain. The increases in hippocampal and corical GPX activity were attenuated by NGF treatment, whereas the neurotrophin induced an increase in GRD activity in the striatum of aged rats. These resultas point out GRD and GPX as possible targets of the neurotrophic effects


Assuntos
Humanos , Glutationa , Fatores de Crescimento Neural , Envelhecimento
15.
La Habana; s.n; 1998. 7 p. graf.
Não convencional em Inglês | CUMED | ID: cum-13218

RESUMO

Neurotrophins, like the nerve growth factor (NGF), trigger a variety of biological effects in their targets. Stimulating effects on antioxidant defenses have been postulated to underlie neurotrophic influence on neuron survival and maintenance. To test whether NGF is capable of inducing changes in glutathione-related enzymes in the aged cognitively impaired brain, glutathione reductase (GRD), glutathione S-transferase (GST) and total glutathione peroxidase (GPX) activities were measured in the striatum, septum, hippocampus and fraontal cortex of four Sprague-Dawley rat groups: young (2 months old), aged (20 months old) untreated, aged cytochrome c-treated, and aged NGF-treated (icv delivery, 34 æg during 28 days). All the aged rats utilized in the study were memory impaired according to their performance in the Morris water maze test. These aged rats showed increases in the activities of septal and hippocampal GST, as well as, in the hippocampal, striatal and cortical GPX. These increases could be interpreted as compensatory responses to cope with the oxidative damage that has been accumulated by the aged brain. The increases in hippocampal and corical GPX activity were attenuated by NGF treatment, whereas the neurotrophin induced an increase in GRD activity in the striatum of aged rats. These resultas point out GRD and GPX as possible targets of the neurotrophic effects


Assuntos
Humanos , Glutationa , Fatores de Crescimento Neural , Envelhecimento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...